Cancers, Vol. 15, Pages 1985: Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample
Conclusions: Long-term systemic anticoagulant use is associated with better clinical outcomes in terms of decreased risks of some life-threatening events, in-hospital death, and prolonged LOS among hospitalized patients with pancreatic cancer in the U.S.
Source: Cancers - Category: Cancer & Oncology Authors: Yen-Min Huang Hsuan-Jen Shih Yi-Chan Chen Tsan-Yu Hsieh Che-Wei Ou Po-Hsu Su Shih-Ming Chen Yun-Cong Zheng Li-Sung Hsu Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Databases & Libraries | Heart | Heart Attack | Heart Failure | ICD-10 | Pancreas | Pancreatic Cancer | Study | Thrombosis | Urology & Nephrology